Rafael Santisteban-Rivas

Barcelona, CT 08193, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

The TM3-ECL2 disulfide bridge is a structural checkpoint for productive Golf coupling of the odorant receptor OR51E2.

The TM3-ECL2 disulfide bridge is a structural checkpoint for productive Golf coupling of the odorant receptor OR51E2.

Journal: Biochemical pharmacology

Published: April 22, 2026

Quantifying Heteromer Partitioning Reveals Inflammation-Dependent Redistribution of Microglial Adenosine A2A and Cannabinoid CB2 Receptors.

Quantifying Heteromer Partitioning Reveals Inflammation-Dependent Redistribution of Microglial Adenosine A2A and Cannabinoid CB2 Receptors.

Journal: Glia

Published: January 29, 2026

Neuroprotective Role of Cannabinoid CB1 and GPR55 Receptors in a Cell Model of Multiple Sclerosis.

Neuroprotective Role of Cannabinoid CB1 and GPR55 Receptors in a Cell Model of Multiple Sclerosis.

Journal: Molecular neurobiology

Published: November 01, 2025

Cannabidiol biases A2A-CB2 receptor heteromer function by decoupling β-arrestin signaling from complex formation.

Cannabidiol biases A2A-CB2 receptor heteromer function by decoupling β-arrestin signaling from complex formation.

Journal: Biochemical pharmacology

Published: July 10, 2025

Cannabidiol releases CB1R from A2AR repression in ischemic stroke.

Cannabidiol releases CB1R from A2AR repression in ischemic stroke.

Journal: Neurobiology of disease

Published: April 07, 2025

GPR88 impairs the signaling of kappa opioid receptors in a heterologous system and in primary striatal neurons.

GPR88 impairs the signaling of kappa opioid receptors in a heterologous system and in primary striatal neurons.

Journal: Neuropharmacology

Published: June 20, 2024

The Potential of Metabolomics to Find Proper Biomarkers for Addressing the Neuroprotective Efficacy of Drugs Aimed at Delaying Parkinson's and Alzheimer's Disease Progression.

The Potential of Metabolomics to Find Proper Biomarkers for Addressing the Neuroprotective Efficacy of Drugs Aimed at Delaying Parkinson's and Alzheimer's Disease Progression.

Journal: Cells

Published: June 18, 2024

Olfactory receptors in neural regeneration in the central nervous system.

Olfactory receptors in neural regeneration in the central nervous system.

Journal: Neural regeneration research

Published: April 30, 2024

Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons.

Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons.

Journal: NPJ Parkinson's disease

Published: April 10, 2024

Potential of CBD Acting on Cannabinoid Receptors CB1 and CB2 in Ischemic Stroke.

Potential of CBD Acting on Cannabinoid Receptors CB1 and CB2 in Ischemic Stroke.

Journal: International journal of molecular sciences

Published: April 03, 2024

Heteromers Formed by GPR55 and Either Cannabinoid CB1 or CB2 Receptors Are Upregulated in the Prefrontal Cortex of Multiple Sclerosis Patients.

Heteromers Formed by GPR55 and Either Cannabinoid CB1 or CB2 Receptors Are Upregulated in the Prefrontal Cortex of Multiple Sclerosis Patients.

Journal: International journal of molecular sciences

Published: March 15, 2024

The NADPH Link between the Renin Angiotensin System and the Antioxidant Mechanisms in Dopaminergic Neurons.

The NADPH Link between the Renin Angiotensin System and the Antioxidant Mechanisms in Dopaminergic Neurons.

Journal: Antioxidants (Basel, Switzerland)

Published: September 10, 2023

Showing 1-12 of 41

Last Updated: 09/26/2026